Cincinnati-based medical organization pioneering Alzheimer's detection with cfDNA testing.
EpiFluid, founded in Cincinnati, Ohio, is a medical organization dedicated to pioneering early detection methods for Alzheimer's disease through cfDNA (circulating free DNA) testing. Their core mission is to advance the understanding and diagnosis of neurodegenerative diseases by leveraging cutting-edge epigenomics and computational biology techniques. EpiFluid operates within the Simpson Querrey Institute for Epigenetics, the Department of Biochemistry and Molecular Genetics, and the Robert H. Lurie Comprehensive Cancer Center at Northwestern University Feinberg School of Medicine.
Notable affiliated individuals include researchers and scientists from Northwestern University, who contribute to the lab's innovative approaches in decoding the human genome. EpiFluid has achieved significant milestones in developing high-throughput experimental methods in epigenomics, making impactful strides in early Alzheimer's detection. Their work not only promises to revolutionize diagnostic processes but also aims to improve patient outcomes through earlier intervention.

Epic Sciences
epicsciences.com

Epigentek Group
epigentek.com

EpiCypher
epicypher.com

EpiFinder
epifinder.com

BioFluidica
biofluidica.com

InnoGenomics Technologies
innogenomics.com

Fluent BioSciences
fluentbio.com

Orchid
orchidhealth.com

FloBio
flobiollc.com

Inceptive
inceptive.life

CNine Biosolutions

Envivo Bio
envivo.bio

Molecular Detection

Liquid Genomics

EpigenCare
epigencare.com
Companies similar to EpiFluid include Epic Sciences, Epigentek Group, EpiCypher and EpiFinder.
EpiFluid's headquarters is located in Cincinnati, OH, US.
EpiFluid has 5 employees as of Feb 24, 2024.